Abstract
Loss of cell-cycle control is a hallmark of neoplastic cells. One regulator of the critical G1 to S-phase transition in the cell cycle is the retinoblastoma tumour suppressor protein Rb, which interacts with the E2F family of cell-cycle transcription factors to repress gene transcription required for this transition. Through its interaction with E2F, Rb also regulates genes that control apoptosis. Here we review the roles of Rb in regulating the cell cycle and apoptosis and discuss recent results linking these Rb functions to chromatin-remodelling enzymes.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Lee, W. H. et al. Human retinoblastoma susceptibility gene: cloning, identification, and sequence. Science 235, 1394–1399 (1987).
Fung, Y. K. et al. Structural evidence for the authenticity of the human retinoblastoma gene. Science 236, 1657–1661 (1987).
Friend, S. H. et al. A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature 323, 643–646 (1986).
Weinberg, R. A. The retinoblastoma protein and cell cycle control. Cell 81, 323–330 (1995).
Huang, H.J., et al. Suppression of the neoplastic phenotype by replacement of the RB gene in human cancer cells. Science 242, 1563–1566 (1988).
Nevins, J. R. Toward an understanding of the functional complexity of the E2F and retinoblastoma families. Cell Growth Differ. 9, 585–593 (1998).
Dyson, N. The regulation of E2F by pRB-family proteins. Genes Dev. 12, 2245–2262 (1998).
Horowitz, J. M. et al. Frequent inactivation of the retinoblastoma anti-oncogene is restricted to a subset of human tumour cells. Proc. Natl Acad. Sci. USA 87, 2775–2779 (1990).
Whyte, P. et al. Association between an oncogene and an anti-oncogene: the adenovirus E1A proteins bind to the retinoblastoma gene product. Nature 334, 124–129 (1988).
Dyson, N., Howley, P. M., Munger, K. & Harlow, E. The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 243, 934–937 (1989).
Ludlow, J.W. et al. SV40 large T antigen binds preferentially to an underphosphorylated member of the retinoblastoma susceptibility gene product family. Cell 56, 57–65 (1989).
Sherr, C. J. Cancer cell cycles. Science 274, 1672–1677 (1996).
Lundberg, A. S. & Weinberg, R. A. Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes. Mol. Cell. Biol. 18, 753–761 (1998).
Harbour, J. W., Luo, R. X., Dei Sante, A., Postigo, A. A. & Dean, D. C. Cdk phosphorylation triggers sequential intramolecular interactions that progressively block Rb functions as cells move through G1. Cell 98, 859–869 (1999).
Flemington, E. K., Speck, S. H. & Kaelin, W. J. E2F-1-mediated transactivation is inhibited by complex formation with the retinoblastoma susceptibility gene product. Proc. Natl Acad. Sci. USA 90, 6914–6918 (1993).
Helin, K., Harlow, E. & Fattaey, A. Inhibition of E2F-1 transactivation by direct binding of the retinoblastoma protein. Mol. Cell. Biol. 13, 6501–6508 (1993).
Weintraub, S. J. et al. Mechanism of active transcriptional repression by the retinoblastoma protein. Nature 375, 812–815 (1995).
Sellers, W. R., Rodgers, J. W. & Kaelin, W. J. A potent transrepression domain in the retinoblastoma protein induces a cell cycle arrest when bound to E2F sites. Proc. Natl Acad. Sci. USA 92, 11544–11548 (1995).
Bremner, R. et al. Direct transcriptional repression by pRB and its reversal by specific cyclins. Mol. Cell. Biol. 15, 3256–3265 (1995).
Adnane, J., Shao, Z. & Robbins, P. D. The retinoblastoma susceptibility gene product represses transcription when directly bound to the promoter. J. Biol. Chem. 270, 8837–8843 (1995).
Johnson, D.G., Schwarz, J.K., Cress, W.D. & Nevins, J.R. Expression of transcription factor E2F-1 induces quiescent cells to enter S phase. Nature 365, 349–352 (1993).
Zhu, L., et al. Inhibition of cell proliferation by p107, a relative of the retinoblastoma protein. Genes Dev. 7, 1111–1125 (1993).
Qin, X. Q. et al. The transcription factor E2F-1 is a downstream target of RB action. Mol. Cell. Biol. 15, 742–755 (1995).
Zhang, H. S., Postigo, A. A. & Dean, D. C. Active transcriptional repression by the Rb–E2F complex mediates G1 arrest triggered by p16INK4a, TGFβ, and contact inhibition. Cell 97, 53–61 (1999).
He, S. et al. E2F is required to prevent inappropriate S-phase entry of mammalian cells. Mol. Cell. Biol. 20, 363–271 (2000).
Morris, L., Allen, E. & La Thangue, N. B. Regulation of E2F transcription by cyclin E–Cdk2 kinase mediated through p 300/CBP co-activators. Nature Cell Biol. 2, 232–239 (2000).
Felsenfeld, G. Chromatin as an essential part of the transcriptional mechanism. Nature 355, 219–224 (1992).
Kingston, R. E. & Narlikar, G. J. ATP-dependent remodelling and acetylation as regulators of chromatin fluidity. Genes Dev. 13, 2339–2352 (1999).
Grunstein, M. Histone acetylation in chromatin structure and transcription. Nature 389, 349–352 (1997).
Hassig, C. A. & Schreiber, S. L. Nuclear histone acetylases and deacetylases and transcriptional regulation: HATs off to HDACs. Curr. Opin. Chem. Biol. 1, 300–308 (1997).
Heinzel, T., et al. A complex containing N-CoR, mSin 3 and histone deacetylase mediates transcriptional repression. Nature 387, 43–48 (1997).
Hassig, C. A., Fleischer, T. C., Billin, A. N., Schreiber, S. L. & Ayer, D. E. Histone deacetylase activity is required for full transcriptional repression by mSin3A. Cell 89, 341–347 (1997).
Laherty, C. D. et al. Histone deacetylases associated with the mSin3 corepressor mediate mad transcriptional repression. Cell 89, 349–356 (1997).
Alland, L. et al. Role for N-CoR and histone deacetylase in Sin3-mediated transcriptional repression. Nature 387, 49–55 (1997).
Brehm, A. et al. Retinoblastoma protein recruits histone deacetylase to repress transcription. Nature 391, 597–601 (1998).
Luo, R. X., Postigo, A. A. & Dean, D. C. Rb interacts with histone deacetylase to repress transcription. Cell 92, 463–473 (1998).
Magnaghi, J. L. et al. Retinoblastoma protein represses transcription by recruiting a histone deacetylase. Nature 391, 601–605 (1998).
Lai, A. et al. RBP1 recruits both histone deacetylase-dependent and -independent repression activities to retinoblastoma family proteins. Mol. Cell. Biol. 19, 6632–6641 (1999).
Trouche, D., Cook, A. & Kouzarides, T. The CBP co-activator stimulates E2F-1/DP1 activity. Nucleic Acids Res. 24, 4139–4145 (1996).
Ross, J. F., Liu, X. & Dynlacht, B. D. Mechanism of transcriptional repression of E2F by the retinoblastoma tumour suppressor protein. Mol. Cell 3, 195–205 (1999).
Meloni, A. R., Smith, E. J. & Nevins, J. R. A mechanism for Rb/p130-mediated transcription repression involving recruitment of the CtBP corepressor. Proc. Natl Acad. Sci. USA 96, 9574–9579 (1999).
Tyler, J. K. & Kadonaga, J. T. The ‘dark side’ of chromatin remodelling: repressive effects on transcription. Cell 99, 443–446 (1999).
Holstege, F. C. et al. Dissecting the regulatory circuitry of a eukaryotic genome. Cell 95, 717–728 (1998).
Staehling-Hampton, K., Ciampa, P. J., Brook, A. & Dyson, N. A genetic screen for modifiers of E2F in Drosophila melanogaster. Genetics 153, 275–287 (1999).
Phelan, M. L., Sif, S., Narlikar, G. J. & Kingston, R. E. Reconstitution of a core chromatin remodelling complex from SWI/SNF subunits. Mol. Cell 3, 247–253 (1999).
Dunaief, J. L. et al. The retinoblastoma protein and BRG1 form a complex and cooperate to induce cell cycle arrest. Cell 79, 119–130 (1994).
Singh, P., Coe, J. & Hong, W. A role for retinoblastoma protein in potentiating transcriptional activation by the glucocorticoid receptor. Nature 374, 562–565 (1995).
Trouche, D., Le, C. C., Muchardt, C., Yaniv, M. & Kouzarides, T. RB and hBrm cooperate to repress the activation functions of E2F-1. Proc. Natl Acad. Sci. USA 94, 11268–11273 (1997).
Zhu, L. et al. The pRB-related protein p 107 contains two growth suppression domains: independent interactions with E2F and cyclin/cdk complexes. EMBO J. 14, 1904–1913 (1995).
Knudsen, E. S. & Wang, J. Y. Differential regulation of retinoblastoma protein function by specific Cdk phosphorylation sites. J. Biol. Chem. 271, 8313–8320 (1996).
Knudsen, E. S. & Wang, J. Y. Dual mechanisms for the inhibition of E2F binding to RB by cyclin-dependent kinase-mediated RB phosphorylation. Mol. Cell. Biol. 17, 5771–5783 (1997).
Morgenbesser, S. D., Williams, B. O., Jacks, T. & Depinho, R. A. p 53-dependent apoptosis produced by rb deficiency in the developing mouse lens. Nature 371, 72–74 (1994).
Symonds, H. et al. p 53-dependent apoptosis suppresses tumour growth and progression in vivo. Cell 78, 703–711 (1994).
Bates, S. et al. p14ARF links the tumour suppressors RB and p53. Nature 395, 124–125 (1998).
Pomerantz, J. et al. The Ink 4a tumour suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2’s inhibition of p53. Cell 92, 713–723 (1998).
Lee, E. Y. et al. Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis. Nature 359, 288–294 (1992).
Jacks, T. et al. Effects of an Rb mutation in the mouse. Nature 359, 295–300 (1992).
Clarke, A. R. et al. Requirement for a functional Rb-1 gene in murine development. Nature 359, 328–330 (1992).
Tsai, K. Y. et al. Mutation of E2F-1 suppresses apoptosis and inappropriate S phase entry and extends survival of Rb-deficient mouse embryos. Mol. Cell 2, 293–304 (1998).
Pan, H. & Griep, A. E. Temporally distinct patterns of p53-dependent and p53-independent apoptosis during mouse lens development. Genes Dev. 9, 2157–2169 (1995).
Hsieh, J. K., Fredersdorf, S., Kouzarides, T., Martin, K. & Lu, X. E2F-1-induced apoptosis requires DNA binding but not transactivation and is inhibited by the retinoblastoma protein through direct interaction. Genes Dev. 11, 1840–1852 (1997).
Phillips, A. C., Bates, S., Ryan, K. M., Helin, K. & Vousden, K. H. Induction of DNA synthesis and apoptosis are separable functions of E2F-1. Genes Dev. 11, 1853–1863 (1997).
Phillips, A. C., Ernst, M. K., Bates, S., Rice, N. R. & Vousden, K. H. E2F-1 potentiates cell death by blocking antiapoptotic signalling pathways. Mol. Cell 4, 771–781 (1999).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Harbour, J., Dean, D. Rb function in cell-cycle regulation and apoptosis. Nat Cell Biol 2, E65–E67 (2000). https://doi.org/10.1038/35008695
Issue Date:
DOI: https://doi.org/10.1038/35008695
This article is cited by
-
Heat treatment dependent cytotoxicity of silicalite-1 films deposited on Ti-6Al-4V alloy evaluated by bone-derived cells
Scientific Reports (2020)
-
Application of galangin, an active component of Alpinia officinarum Hance (Zingiberaceae), for use in drug-eluting stents
Scientific Reports (2017)
-
miR-215 functions as an oncogene in high-grade glioma by regulating retinoblastoma 1
Biotechnology Letters (2017)
-
SENP1-modulated sumoylation regulates retinoblastoma protein (RB) and Lamin A/C interaction and stabilization
Oncogene (2016)
-
Synergistic effect of atorvastatin and cyanidin-3-glucoside against angiotensin II-mediated vascular smooth muscle cell proliferation and migration through MAPK and PI3K/Akt pathways
Archives of Pharmacal Research (2016)